A Medical Research Council Randomised Trial of Treatment for Inducing First Plateau Phase ABCM versus Three Courses of AMCM Followed by Oral Weekly Cyclophosphamide.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Cyclophosphamide; Doxorubicin; Melphalan
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms MYELOMA-VIII
- 19 Dec 2013 Biomarkers information updated
- 01 Jul 2010 Planned end date changed from 1 Nov 2000 to 31 Mar 2002 as reported by United Kingdom Clinical Research Network record.
- 01 Jul 2010 New source identified and integrated (United Kingdom Clinical Research Network record 630).